Literature DB >> 77022

Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein.

J J Kopchick, G A Jamjoom, K F Watson, R B Arlinghaus.   

Abstract

Reverse transcriptase (RT; RNA-dependent DNA nucleotidyltransferase) from Rauscher leukemia virus is synthesized in infected cells by way of a read-through poly- rotein of 200,000 molecular weight. This polyprotein (Pr200(gag-pol)) was precipitated by antiserum to RT; in a previous study all the monospecific antisera to gag proteins recognized Pr200(gag-pol). Pr200(gag-pol) contains both p30 and RT peptide sequences. Intermediate RT-related precursors of 145,000 (Pr145(pol)), 135,000 (Pr135(pol)), and 125,000 (Pr125(pol)) molecular weights were specifically recognized by precipitation from infected cell extracts by antiserum to RT. These proteins shared methionine-containing tryptic peptide sequences with a virion polypeptide of 80,000 molecular weight (p80(pol)) precipitate by antiserum to RT. Purification of active RT enzyme from virions labeled with [(3)H]methionine showed that p80(pol) was the major component, based on analysis by gel electrophoresis and tryptic peptide mapping experiments. A polypeptide (Pr80(pol)), similar in size to mature viral p80(pol), was also precipitated from infected cells by antiserum to RT. Its peptide map was nearly identical to that of virion p80(pol). Pulse-chase studies showed that Pr80(pol), Pr125(pol), and Pr135(pol) were stable polypeptides, whereas Pr200(gag-pol) and Pr145(pol) were unstable precursors. Pulse-chase studies with the protein synthesis inhibitor, cycloheximide, showed that the processing of Pr200(gag-pol) occurred for a short time in the absence of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77022      PMCID: PMC392474          DOI: 10.1073/pnas.75.4.2016

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

2.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

3.  C-type virus particles produced by normal mouse spleen-thymus cultures.

Authors:  R B Naso; J B Vidrine; C S Wang; R B Arlinglaus
Journal:  Virology       Date:  1972-02       Impact factor: 3.616

4.  Purification of the DNA polymerase of avian myeloblastosis virus.

Authors:  D L Kacian; K F Watson; A Burny; S Spiegelman
Journal:  Biochim Biophys Acta       Date:  1971-09-24

5.  Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus.

Authors:  K Moelling
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

6.  The nature of the polypeptide chain termination signal.

Authors:  P Lu; A Rich
Journal:  J Mol Biol       Date:  1971-06-14       Impact factor: 5.469

7.  Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay.

Authors:  A Panet; D Baltimore; T Hanafusa
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

8.  Tumor viruses: 1974.

Authors:  D Baltimore
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

9.  Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.

Authors:  I M Verma
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

10.  A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71.

Authors:  R B Naso; L J Arcement; W L Karshin; G A Jamjoom; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  15 in total

1.  Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.

Authors:  M J Roth; P Schwartzberg; N Tanese; S P Goff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA.

Authors:  A T Panganiban
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

3.  Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.

Authors:  C J Sherr; G J Todaro; A Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli.

Authors:  N Tanese; M J Roth; S P Goff
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  The requirement of nonsense suppression for the development of several phages.

Authors:  H Engelberg-Kulka; L Dekel; M Israeli-Reches; M Belfort
Journal:  Mol Gen Genet       Date:  1979-02-26

7.  Protein-coding potential of mouse mammary tumor virus genome RNA as examined by in vitro translation.

Authors:  C Dickson; G Peters
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

8.  Characterization of intracellular precursor polyproteins of Moloney murine leukemia virus.

Authors:  V L Ng; T G Wood; D D Lyons; R B Arlinghaus
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

9.  Polyamines enhance readthrough of the UGA termination codon in a mammalian messenger RNA.

Authors:  M M Hryniewicz; R A Vonder Haar
Journal:  Mol Gen Genet       Date:  1983

10.  Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: identification of an N-terminal 45,000-dalton cleavage product.

Authors:  R B Naso; L H Stanker; J J Kopchick; V L Ng; W L Karshin; R B Arlinghaus
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.